Lumida
/LXRX
⌘K
Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

LXRX
$2.39USD↑+6.70%+0.15 today

MARKET CAP

1.1B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$2 – $2

52W RANGE

$1
$3

AI Summary

Stalk
Buy NowMedium

In a Stage 2 advancing market within a long-term uptrend, medium-term bias remains bullish supported by persistent higher highs/lows and rising moving averages; short-term timing is favorable as price pulls back and holds the rising 9 and 21 EMAs, warranting a Buy Now stance at the EMA support zone.

  • ↑Full-year 2025 revenue $49.8M, up 720% since 2022
  • ↑Licensing revenue of $17.5M from Novo Nordisk due H2 2026
  • ↓2025 net loss of $50.3M highlights persistent profitability issues
Full analysis →

News for Lexicon Pharmaceuticals Inc loads here via client-side fetch to /api/news/lxrx.